NASDAQ: IMVT - Immunovant, Inc.

Rentabilidade por seis meses: -35.75%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Immunovant, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Immunovant, Inc.

Immunovant, Inc., клиническая биофармацевтическая компания, разрабатывает моноклональные антитела для лечения аутоиммунных заболеваний. Он разрабатывает IMVT-1401, новое полностью человеческое моноклональное антитело, которое избирательно связывается и ингибирует неонатальный фрагмент кристаллизующегося рецептора, который находится в фазе IIa клинических испытаний для лечения миастении и заболеваний глаз щитовидной железы, а также завершил инициацию фазы II клинических испытаний для лечения тяжелой аутоиммунной гемолитической анемии.

mais detalhes
Штаб-квартира компании находится в Нью-Йорке, штат Нью-Йорк. Immunovant, Inc. является дочерней компанией Roivant Sciences Ltd. .
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2019-06-21
ISIN US45258J1025
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://immunovant.com
Цена ао 18.19
Alteração de preço por dia: 0% (18.19)
Alteração de preço por semana: -3.65% (18.88)
Alteração de preço por mês: -10.96% (20.43)
Alteração de preço em 3 meses: -30.25% (26.08)
Mudança de preço em seis meses: -35.75% (28.31)
Mudança de preço por ano: -44.07% (32.52)
Mudança de preço em 3 anos: +255.97% (5.11)
Mudança de preço em 5 anos: +35.34% (13.44)
Mudança de preço desde o início do ano: -23.83% (23.88)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 0 0
P/BV 7.03 1
P/E 0 0
EV/EBITDA -13.72 0
Total: 2

Eficiência

Nome Significado Nota
ROA, % -48.37 0
ROE, % -52.91 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.000511 10
Total: 9.2

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 0 0
Rentabilidade Ebitda, % 311.55 10
Rentabilidade EPS, % 21.94 4
Total: 6.8
Mais detalhes

Instituições Volume Compartilhar, %
FMR, LLC 7875822 5.42
Vanguard Group Inc 5827798 4.01
Blackrock Inc. 4530716 3.12
State Street Corporation 3216376 2.21
Point72 Asset Management, L.P. 2666883 1.84
Perceptive Advisors LLC 2328082 1.6
Price (T.Rowe) Associates Inc 1602562 1.1
Armistice Capital, LLC 1436000 0.99
Alpine Global Management, LLC 1398372 0.96
Adage Capital Partners GP L.L.C. 1331780 0.92

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
Virtus LifeSci Biotech Clinical Trials ETF 0.86953 63.04 0.33
Invesco Nasdaq Biotechnology ETF 0.41665 28.58 0.8565
Future Tech ETF 0.4142 426.34 0.8416
Principal Healthcare Innovators ETF 0.4142 618.5 0.8416
Direxion Daily S&P Biotech Bull 3x Shares 0.34262 4067.92 0.25924
ProShares Ultra Nasdaq Biotechnology 0.28046 51.7 0.85651
Vanguard Russell 2000 Growth ETF 0.13 23.05 0.60264
iShares Russell 2000 Growth ETF 0.12618 38.04 0.6026
BNY Mellon US Small Cap Core Equity ETF 0.0882 30.07 1.75333
Vanguard U.S. Momentum Factor ETF 0.08 30.05 1.05834
iShares Morningstar Small-Cap Growth ETF 0.07779 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.07779 587.89 0.72598
Vanguard Russell 2000 ETF 0.07 17.16 1.48801
Vanguard Small Cap Value ETF 0.06 17.27 2.19419
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.04867 21.79 1.42082
Schwab U.S. Small-Cap ETF 0.04482 17.47 1.51433
iShares ESG Aware MSCI USA Small-Cap ETF 0.04462 18.09 1.49366
iShares Morningstar Small-Cap ETF 0.03957 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.03957 391.25 1.60498
ProShares UltraPro Russell2000 0.03667 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.02319 3 1.46057
ProShares Hedge Replication ETF 0.01021 5.92 1.47892
Humankind US Stock ETF 0.00717 18.81 1.99919
SPDR Portfolio MSCI Global Stock Market ETF 0.00641 17.99 2.19607
Dimensional U.S. Equity ETF 0.00488 31.53 1.3557
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00362 21.94 1.69572
iShares Russell 3000 ETF 0.00319 24.83 1.43482
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.00317 33 1.42661
Dimensional U.S. Core Equity 2 ETF 0.00303 30.76 1.47098
Schwab U.S. Broad Market ETF 0.00297 24.86 1.43354
Dimensional US Core Equity Market ETF 0.00134 30.98 1.40618
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.11209.111.28



Supervisor Cargo Pagamento Ano de nascimento
Dr. Peter Salzmann M.B.A., M.D. CEO & Director 1.02M 1968 (57 anos)
Dr. Julia G. Butchko Ph.D. Chief Development Officer 531k 1971 (54 ano)
Ms. Lauren Schrier M.B.A. Vice President of Marketing N/A
Dr. William L. Macias M.D., Ph.D. Chief Medical Officer 719.88k 1958 (67 anos)
Ms. Eva Renee Barnett M.B.A. Chief Financial Officer 871.07k 1980 (45 anos)
Mr. Mark S. Levine Chief Legal Officer & Corporate Secretary N/A 1973 (52 ano)
Dr. Jay S. Stout Ph.D. Chief Technology Officer N/A 1963 (62 ano)
Ms. Christine Blodgett Vice President of Human Resources N/A
Dr. Frank M. Torti M.B.A., M.D. Executive Chairperson of the Board 92.5k 1979 (46 anos)
Mr. Andy Deig Senior Vice President of Strategic Finance

Endereço: United States, New York, NY , 320 West 37th Street - abrir no Google Maps, abrir mapas Yandex
Site: http://immunovant.com